Optimizing SUSAR distribution in a connected– but unharmonized–world

April 4, 2019 Steven Beales

In this interview, Steven Beales, senior vice president, IT, and market owner, safety solutions and Joe O’Rourke, vice president, business development talk through some of the difficulties Sponsors face when it comes to safety letter distribution, and how to overcome them.

About the Author

Steven Beales

An expert in the field of safety reporting technology, Mr. Beales has 25 years of experience in IT, and has spent over 16 years in the pharmaceutical industry. He joined WCG ePharmaSolutions in 2009 and led implementation of the company’s Clinical Trial Portal at Genentech across 100+ countries. In 2015, he led implementation of the Clinical Trial Safety Portal at a top 5 pharma organization, which included a data-driven rules engine configured with safety regulations from those countries, which saved this organization hundreds of millions of dollars. Over 50 million safety alerts have been distributed by these two portals via the cloud. Prior to joining WCG ePharmaSolutions, Mr. Beales was the Chief Software Architect at mdlogix, where he led the implementation of the CTMS systems for Johns Hopkins University, Washington University at St. Louis, the University of Pittsburgh, and the Interactive Autism Network for Autism Speaks.

Follow on Linkedin More Content by Steven Beales
Previous Flipbook
Q&A with Dr. Nathaniel Katz
Q&A with Dr. Nathaniel Katz

Dr. Katz, Chief Science Officer and the founder of Analgesic Solutions, shared his insights during a recent...

Next Flipbook
Quality First: Using Data to Inform Site Selection in CNS
Quality First: Using Data to Inform Site Selection in CNS

WCG MedAvante-ProPhase espouses a rather simple philosophy: minimize variability, generate cleaner data.

Request a Genetics in Clinical Trials training session

What You'll Learn